Effects of intranasal Escherichia coli on glucolipid metabolism in high-fat diet-induced obese mice

AIM: To study whether the pulmonary infection of Escherichia coli (E. coli) interferes the glucolipid metabolism in high-fat diet-induced obese mice. METHODS: High-fat diet-induced obese mice (n=48) and normal chow-fed control mice (n=48) were intranasally infused with 40 μL fluid containing 4×10⁹ CFUs E. coli. The serum, periepididymal adipose tissue and liver were obtained at 0 d, 1 d, 2 d, 3 d and 4 d after infection. The body mass, periepididymal adipose tissue and liver were weighed, and the levels of fasting blood glucose (FBG), fasting blood insulin (FINS), free fatty acid (FFA) and very-low-density lipoprotein (VLDL) were measured by ELISA. The serum total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C), and hepatic TG contents were detected, and the hepatic steatosis was observed under microscope with oil red O staining. RESULTS: Compared with day 0, the body mass, fat mass and fat index were decreased significantly from day 1 to day 4 after infection (P<0.05). The levels of FBG, FINS and HOMA-IR were apparently raised from day 2 to day 4 after infection (P<0.05). The contents of serum FFA, TG and VLDL were increased markedly from day 1 to day 4 after infection (P<0.05). However, the concentrations of serum TC, LDL-C and HDL-C were decreased obviously from day 1 to day 3 (P<0.05). The liver mass, liver index and TG content were significantly increased from day 1 to day 4 (P<0.05). Consistently, the lipid droplet accumulation in the liver cells was increased obviously at day 2 and day 4 after infection. Compared with control group, except the levels of serum TC, LDL-C and HDL-C in obese group substantially decreased, the other indexes were increased by different degrees during the whole experiment period (P<0.05). CONCLUSION: Pulmonary infection of Escherichia coli exacerbates the disorder of glucose and lipid metabolism in high-fat diet-induced obese mice, which contributes the development of insulin resistance and hepatic steatosis.     

Protective effect of adiponectin on glucose and lipid metabolism by suppressing MHCⅡ expression

AIM: To investigate whether the protective effect of adiponectin on glucose and lipid metabolism is achieved through down-regulating major histocompatibility complex class Ⅱ (MHCⅡ) in the adipose tissue. METHODS: Adiponectin knockout (KO) mice and C57BL/6(WT) mice were fed with high-fat diet and standard diet for 24 weeks, respectively. The body weight, fasting blood glucose (FBG), fasting insulin (FINS), homeostasis model assessment of insulin resistance (HOMA-IR), triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), hepatic histology, and class Ⅱ trans-activator (CⅡTA), histocompatibility 2 class Ⅱ antigen E beta (H2-Eb1) and cluster of differentiation 74(CD74) mRNA and MHC Ⅱ protein levels in adipose tissue were measured at sacrifice. siRNA targeting MHC Ⅱ and overexpression vector was used in 3T3-L1 cells to explore the effect of adiponectin on the protein level of MHCⅡ. RESULTS: The levels of body weight, FBG, FINS, HOMA-IR, TC, TG, LDL-C, hepatic steatosis, CⅡTA, H2-Eb1 and CD74 mRNA expression, and MHCⅡ protein expression in the KO mice were higher than those in the WT mice that fed with high-fat diet or standard diet. In 3T3-L1 cells, inhibition of adiponectin reversed MHC Ⅱ protein level induced by specific siRNA. The expression of MHC Ⅱ in adipocytes decreased after adiponectin was overexpressed. CONCLUSION: Adiponectin improves glucose and lipid metabolism through suppressing the expression of MHCⅡ in the adipose tissue.     

Effects of Retinervus luffae fructus on mRNA expression of low-density lipoprotein receptor in hyperlipidemia mice

AIM: To observe the effects of Retinervus luffae fructus (RLF) on mRNA expression of low-density lipoprotein receptor (LDL-R) in hyperlipidemia mice. METHODS: Mice were fed with high fat diet to induce a hyperlipidemia model. By using xuezikang, a Chinese medicine, as a positive control, the effect of RLF on serum total cholesterol (TC) and level of low density lipoprotein cholesterol (LDL-C) in mice were observed. The liver total RNA was extracted by Trizol method. The LDL-R mRNA expression was determined by RT-PCR. RESULTS: (1) The levels of TC ［(5.71±0.82) mmol/L］ and LDL-C ［(3.99±1.12) mmol/L］ in hyperlipidemia (HPL) group were higher than those in control (P<0.01). The levels of TC ［(3.65±0.28) mmol/L］ and LDL-C ［(2.74±0.54) mmol/L］ in RLF treatment group, and the levels of TC ［(3.94±0.65) mmol/L］ and LDL-C ［(3.00±0.23) mmol/L］ in positive control (PC) group were lower than those in HPL group (P<0.01). (2) The level of hepatic LDL-R mRNA expression was lower in HPL group than that in control group (P<0.01). Compared to HPL group, significant increases in hepatic LDL-R mRNA expression in RLF treatment group and PC group (P<0.01) were observed. CONCLUSION: Retinervus Luffae Fructus exerts obviously lipid-lowering effect and enhances the hepatic LDL-R mRNA expression in experimental hyperlipidemia mice.     

Effect of puerarin on myocardial injury in KKAy diabetic mice

AIM:To observe the effect of puerarin on myocardial injury according to the time of occurrence of myocardial injury in the development of type 2 diabetic mice. METHODS: The serum levels of glucose (GLU), triglyceride (TG), total cholesterin (TC), low density lipoprotein-cholesterol (LDL-C) and high density lipoprotein-cholesterol (HDL-C) in 17-week, 20-week, 24-week, 28-week KKAy mice were detected by automatic biochemical methods. The apoptotic percentage of cardiomyocytes was examined by flow cytometry. The expressions of bax and bcl-2 mRNA in cardiomyocytes were detected by RT-PCR. Caspase-3 expression in cardiomyocytes was determined by immunohistochemical staining. RESULTS: Compared to normal control mice, not only GLU level increased, but also the levels of TG, TC, LDL-C, HDL-C in 20-week, 24-week and 28-week KKAy mice increased apparently (P<0.01). Apoptosis of cardiomyocytes in KKAy mice began to show up at 28-week. The expression of bax mRNA increased and expression of bcl-2 mRNA reduced. At the same time, the expression of caspase-3 increased. Puerarin obviously decreased the apoptotic percentage of cardiomyocytes, reduced the expression level of bax mRNA, improved the expression level of bcl-2 mRNA (P<0.01), inhibited the expression of caspase-3 (P<0.01). CONCLUSION:Myocardial injury exits in type 2 diabetic mice. Mitochondria apoptotic pathway might participate in the hurting course.     

巴氏蘑菇多糖对糖尿病小鼠脂代谢紊乱的干预作用

选择健康雄性昆明小鼠随机分组,建立糖尿病小鼠模型后分别灌胃不同剂量的巴氏蘑菇(Agaricus blazei)多糖(低、中和高剂量组分别灌胃50、100和200mg/kg/d),阳性对照组灌胃200mg/kg/d阿卡波糖,正常对照和模型组灌胃生理盐水,7周后考察巴氏蘑菇多糖对糖尿病小鼠脂代谢的影响。结果表明:与糖尿病模型组相比,多糖各剂量组和阳性对照组空腹血糖值和血清总胆固醇含量均显著下降;多糖中、高剂量组和阳性对照组的血清甘油三酯含量也显著下降;与模型组相比,附睾脂肪中阳性对照组的glut4、pi3k、akt1和akt2mRNA的表达量均显著升高,多糖组中glut4(低、中和高剂量组)、akt1(低、中和高剂量组)、akt2(中和高剂量组)和pi3k(高剂量组)mRNA的表达量显著升高。     

Effects of Shan He Jian Fei Granule on the expression of leptin,adiponectin and resistin in obese rats induced by high-fat feeding

AIM: To study the effects of Shan He Jian Fei Granule (SHJFG), a Chinese medicine, on weight-reduction and fat-decrease in adiposity rats, and to observe the changes of leptin, adiponectin and resistin. METHODS: After the models were prepared successfully, the rats were randomly divided into four groups: normal group, low dosage, middle dosage, high dosage and obesity control group. After 8 weeks interference with SHJFG, the weight and the naso-anal length of each rat was measured and Lees index were calculated. The levels of TG, TC, LDL, HDL and leptin in serum were carefully determined. The gene expressions of adiponectin and resistin in adipose tissues of rats were determined by RT-PCR. RESULTS: Compared to high-fat diet group, the body weights, the Lees indexes, the weight of fat tissues and levels of TG, TC, LDL and leptin in SHJFG groups significantly decreased (P<0.05). Adiponectin mRNA expression in SHJFG group significantly increased (P<0.05), and the resistin mRNA expression also significantly increased. CONCLUSION: SHJFG significantly decreases the body weight and the serum levels of TG, TC and LDL in obese rats. The effects of SHJFG in raising the mRNA expressions of adiponectin and resistin in fat tissues may be one of the main role that results in lowering body weight in obese rats.     

Role of Huoxue Jiangzhi Recipe in preventing and treating fatty liver in mice

AIM: To explore the role of Huoxue Jiangzhi Recipe in preventing and treating fatty liver in mice and its underlying mechanisms. METHODS: Healthy Kunming mice were fed with high-fat diet and treated intragastrically with different doses of Huoxue Jiangzhi Recipe (compound of ginseng, panax notoginseng and rhizoma gastrodiae, named as GST) for 2 weeks. The levels of blood lipids and triglyceride (TG) in hepatic tissues were measured. Meanwhile, liver index and hepatic pathology were observed. The optimized dosage of Huoxue Jiangzhi Recipe was determined by the experiments. The mice were divided into normal control group (NC group, fed with normal diet) and model group (fed with high-fat diet). The model mice were subdivided into 3 subgroups 12 weeks later: HF group (fed continuously with high-fat diet), ND group (fed with normal diet), GSL group (fed with normal diet and treated intragastrically with GSL). The mice in NC, HF and ND groups were given distilled water by gastric perfusion. Two weeks later, all mice were killed, and blood was collected for measuring serum total cholesterol (TC),TG,high-density lipoprotein-cholesterol (HDL-C), low-density lipoprotein-cholesterol (LDL-C) contents, hepatic TC, TG, malondialdehyde (MDA) levels and superoxide dismutase (SOD) activity were detected. Moreover, liver index and hepatic pathology were also observed. The mRNA expression of peroxisome proliferator-activated receptor alpha (PPARα) and cytochrome-P450 2E1 (CYP2E1) in the liver was examined by RT-PCR. RESULTS: GST significantly decreased serum lipid, hepatic lipid and MDA levels and elevated SOD activity. Furthermore, GST markedly reduced liver index, improved hepatic adipose infiltration, increased PPARα mRNA expression and inhibited CYP2E1 mRNA expression. CONCLUSION: GST is effective in the treatment of fatty liver in mice by up-regulating PPARα, thus reducing serum and hepatic TG levels, down-regulating CYP2E1 and inhibiting lipid peroxidation.     

Expression of SR-A II and CD36 in white blood cells correlate with plasma AGEs levels and diabetic complications

AIM: To investigate the correlation of the expression of scavenger receptors SR-A II and CD36 in white blood cells (WBCs) with the plasma levels of advanced glycosylation end products (AGEs) and different diabetic complications.METHODS: Blood samples were collected from 78 patients with diabetic complications. The levels of plasma AGEs were determined by using spectrofluorimetry. RNA in WBCs was extracted with Trizol reagent and the mRNA levels of SR-A II and CD36 were determined by RT-PCR. RESULTS: In the patients tested, the mRNA level of SR-A Ⅱ was found to be the highest in those with diabetic nephropathy, and lowest in those with fatty liver. The expression of CD36 was found to be the highest in diabetic patients with fatty liver and lowest in those with coronary heart disease. The expression of both receptors in WBCs showed significantly higher levels in diabetic patients with hypertension, and lower in those with cataract. The plasma levels of AGEs negatively correlated with mRNA levels of CD36 (r=-0.89,P<0.01), while positively correlated with SR-A II mRNA levels (r=-0.82, P< 0.05).CONCLUSION: The increased plasma levels of AGEs may stimulate the expression of SR-A II in WBCs, and higher expression of SR-A Ⅱ and CD36 was significantly related to diabetic complications, nephropathy and fatty liver, respectively. However, low expression of CD36 in some diabetic patients with complications might be important causes for their high plasma AGEs levels.     

Effect of tanshinone ⅡA on liver lipid deposition and ferroptosis-related protein expression in ApoE-/- mice

AIM To observe the effect of tanshinone ⅡA on liver lipid deposition and ferroptosis-related protein expression in ApoE^-/- mice. METHODS Thirty-two ApoE^-/- mice were randomly divided into model group, high-dose (60 mg/kg) tanshinone ⅡA group, low-dose (30 mg/kg) tanshinone ⅡA group and simvastatin group, and C57BL/6J mice (n=8) were used as normal control group. The mice in normal control group were given the basic feeding, while the others were given high-fat diet. The mice in tanshinone ⅡA groups and simvastatin group were given corresponding drugs. The mice in normal control group and model group were intraperitoneally injected with equal volume of saline. Eight weeks later, the serum levels of triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) were tested by automatic biochemistry analyzer. The liver tissues were stained with HE and oil red O. The contents of reactive oxygen species (ROS) and glutathione (GSH) in liver tissues of the mice were measured by commercially available kits. The liver glutathione peroxidase 4 (GPX4) and p53 were detected by immunohistochemical method. The protein and mRNA expression levels of ferroptosis-related factors GPX4, xCT/SLC7A11, p53 and ferritin heavy chain 1 (FTH1) were determined by Wes automatic Western blot quantitative analysis system and RT-qPCR. RESULTS Compared with normal control group, the serum levels of TC, TG and LDL-C in model group were increased significantly (P<0.05 or P<0.01), and HDL-C did not change significantly. The fat vacuoles were clearly visible in liver tissue. The content of ROS in liver tissue was increased significantly,and GSH was decreased significantly (P<0.01). The mRNA and protein expression levels of p53 were increased significantly, and GPX4, xCT/SLC7A11 and FTH1 were decreased significantly (P<0.05 or P<0.01). Compared with model group, tanshinone ⅡA significantly decreased the serum levels of TC, TG and LDL-C (P<0.05 or P<0.01), and HDL-C did not change significantly. High-dose and low-dose tanshinoneⅡA also significantly decreased the degree of steatosis, and the size of lipid droplets. The content of ROS in liver tissues was decreased significantly, and GSH was increased significantly (P<0.01). The mRNA and protein expression levels of GPX4, xCT/SLC7A11 and FTH1 were increased significantly, and p53 were decreased significantly (P<0.05 or P<0.01). CONCLUSION Tanshinone ⅡA reduces liver lipid deposition and lipid peroxidation damage in ApoE^-/- mice, which may be related to the intervention of ferroptosis-related proteins in the liver cells.     

Hypothalamic expression of orexin A and lipid metabolism disorder in rats with alimentary obesity

AIM: To evaluate the effect of orexin A in rat hypothalamus on lipid metabolism disorder in rats with alimentary obesity induced by high-fat diet.METHODS: The rat model of alimentary obesity was induced by high-fat diet. The levels of insulin, triglyceride (TG) and total cholesterol (TC) in the serum were detected by luminescent immunoassay and enzymic method. The mRNA expression of orexin A in rat hypothalamus was determined by real-time PCR.RESULTS: There were statistically significant differences of weight, body fat content, and Lee's index between high-fat diet group and control group after 8-week feeding of high-fat diet. Compared to control animals, the levels of insulin, TG and TC in the rats with alimentary obesity significantly increased by 50％, 94％ and 43％, respectively (P<0.05). The expression of orexin A in rat hypothalamus significantly decreased by 57％, and had significant negative correlation with Lee's index, insulin, TG and TC. Their correlation coefficients were r=-0.798 (P<0.05), r=-0.868 (P<0.05), r=-0.981(P<0.05) and r=-0.815 (P<0.05), respectively. CONCLUSION: Alimentary obesity and lipid metabolism disorder induced by high-fat diet are correlated with down-regulation of orexin A expression in rat hypothalamus.     

Effect of GLP-1 receptor agonist on lipolysis in adipose tissue of obese mice and its underlying mechanism

AIM: To investigate the effects of glucagon-like peptide-1(GLP-1) receptor agonist exendin-4 on white adipose tissue (WAT) and the underlying mechanisms. METHODS: Male C57BL/6J mice (8 weeks) were challenged by high-fat diet for 12 weeks, and were randomly divided into saline group and exendin-4 group. The mRNA expression of sirtuin 1(SIRT1), adipose triglyceride lipase (ATGL), TNF-α and adiponectin of WAT was detected by real-time PCR. 3T3-L1 adipocytes or mouse embryonic fibroblasts cells were treated with exendin-4 for 24 h. The protein levels of SIRT1, ATGL and hormone-sensitive lipase (HSL) were determined by Western blot.RESULTS: Exendin-4 significantly decreased epididymal fat weight, fasting blood glucose and serum triglyceride levels (P<0.05), and reduced body weight and serum TNF-α level. The mRNA expression of SIRT1, ATGL and adiponectin in WAT was all significantly up-regulated by exendin-4, which were contrary to the down-regulation of TNF-α mRNA expression (P<0.05). Exendin-4 promoted the protein expression of SIRT1, ATGL, and HSL in 3T3-L1 adipocytes in a dose-dependent manner. Less lipid droplets with up-regulation of lipolytic protein expression were observed when combined with SIRT1 agonist treatment, which were suppressed by SIRT1 inhibitor. Deletion of SIRT1 led to larger adipocytes with more lipid droplets, and the effect of exendin-4 on the lipolysis disappeared when SIRT1 was deficient.CONCLUSION: Exendin-4 promotes lipolysis in WAT of obese mice via activation of SIRT1.     

Improvement of insulin sensitivity by osteocalcin inhibits inflammation in the adipose tissue of obese mice

AIM: To explore the improving effect of osteocalcin on obesity-related insulin resistance and inflammation in the adipose tissue of obese mice.METHODS: The C57BL/6 mice were fed with high-fat diet for 12 weeks to obtain obese mice. Osteocalcin (30 ng/kg or 3 ng/kg) and saline solution (control) were intraperitoneally injected for other 4 weeks. The fat mass, body weight, serum triglycerides and serum free fatty acid were analyzed. Intraperitoneal glucose tolerance test and insulin tolerance test were carried out. Macrophage infiltration degree in the adipose tissue was observed by immunohistochemical staining. The mRNA expression of monocyte chemotactic protein-1 (MCP-1) and CD68 was detected by real-time fluorescence quantitative PCR.RESULTS: Osteocalcin (30 ng/kg or 3 ng/kg) treatment for 4 weeks significantly reduced the body weight, fat mass and insulin level, and improved abnormal glucose tolerance and insulin resistance in the obese mice. Moreover, the macrophage infiltration decreased, and the mRNA expression of MCP-1 and CD68 was down-regulated in the adipose tissue of obese mice treated with osteocalcin at 30 ng/kg.CONCLUSION: Osteocalcin at 30 ng/kg significantly reduces body weight and fat mass, and attenuates the severity of insulin resistance through down-regulating the mRNA expression of MCP-1 and CD68 and inbihiting macrophage infiltration in the adipose tissue of obese mice induced by high-fat diet.     

Antioxidant and serum lipid lowering effects of luffa cylindrical on experimental hyperlipidemia mice

AIM: To observe the antioxidation and the serum lipid lowing effects of polyphenols in luffa cylindrical on experimental hyperlipidemia mice. METHODS: Acetone was used to extract polyphenols from luffa cylindrical. The content of polyphenols was determined by Folin-ciocalteau method. The inhibitory efficacy of the extracts from luffa cylindrical to the production of OH· free radical was measured. Kunming mice were used to establish the hyperlipidemia model by feeding high fat diet. The freeze-dried fresh luffa cylindricals was added to the treated animals, xuezikang was also used as a positive control. After feeding high-fat food for 14 days, serum were collected to measure the total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL-C) and superoxidedismutase (SOD). The liver tissue was also collected for determining malonaldehyde (MDA) content. RESULTS: (1) Content of polyphenols in fresh luffa cylindrical was （0.3±0.1）g /kg. (2) The polyphenol extracts from fresh luffa cylindrical had a strong efficacy to inhibit the production of OH· free radicals. (3) The trend of body weight gain in groups LC1 (low dosage luffa cylindrical) and LC2 (high dosage luffa cylindrical) became slow down obviously, compared with that in group HPL (high-lipid model). (4) The levels of TC (4.19±0.37)mmol/L and LDL-C (2.77±0.79)mmol/L in group LC1, TC (3.56±0.55)mmol/L and LDL-C (2.34±0.41)mmol/L in group LC2, TC (4.59±0.96)mmol/L and LDL-C (3.25±0.67)mmol/L in group PC (positive control) were all lower than those in group HPL(P<0.01), which the decrease in the levels of TC and LDL-C in group LC2 was the most obvious. (5) SOD levels in the serum of mice in groups LC1 and LC2 were (337.00±29.73)U/mL and (349.00±9.99)U/mL respectively, which were higher than those in groups HPL and blank control, therein the SOD level in group LC2 increased obviously(P<0.01) compared with group HPL. The MDA levels in liver tissue in group LC2 was lower than those in control. CONCLUSION: Polyphenols in the luffa cylindrical are comparatively strong antioxidant. They effectively decrease the liver index and serum lipid in experimental mice.     

Anthocyanins attenuates hepatic fibrosis and inflammation in non-alcoho-lic fatty liver disease mice

AIM:To explore the therapeutic effect of anthocyanins from Fructus Acanthophorae on high-fat diet-induced non-alcoholic fatty liver disease (NAFLD) in mice and the potential mechanism. METHODS:NAFLD mouse model was established by high-fat diet, and interferred with anthocyanins. The liver weight, and serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), triglyceride (TG), total cholesterol (TC) and low-density li-poprotein cholesterol (LDL-C) were measured. The liver tissues were staining with HE, Oil Red O and Masson's trichrome. The protein levels of inflammatory factors tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), IL-6 and IL-10 in the liver tissues were determined by Western blot. The liver macrophage, white blood cell and mononuclear cell infiltration was detected by immunohistochemical method. The chemokines CCL7 and MCP-1 were also measured by immunohistochemical method. RESULTS:Anthocyanins significantly inhibited the increases in the liver weight, ALT, AST, TG, TC and LDL-C induced by high-fat diet. Anthocyanins attenuated the liver fibrosis and inflammatory cell infiltration caused by high-fat diet, and reduced the levels of inflammatory factors TNF-α, IL-1β, IL-6, IL-10 and inflammatory chemokines CCL7 and MCP-1 in the liver tissues. CONCLUSION:Anthocyanins significantly alleviate non-alcoholic fatty liver disease caused by high-fat diet though reducing inflammatory factors, inflammatory cell infiltration and inflammatory chemokines.     

Effect of high fat/cholesterol diet on lipid metabolism and intimal lesion of aorta in treble genes mutant mice

AIM: To clarify the effects of high fat/cholesterol diet on lipid metabolism and atherogenesis in treble genes mutant mice. METHODS: ApoE-/-/LDLR-/-/Leprdb/db mice were generated by cross apolipoprotein E, lower density lipoprotein receptor gene knockout mice with leptin receptor gene spontaneous point mutants. The mice were fed with high fat/cholesterol diet from 22-day-old. The total plasma cholesterol (TC), triglyceride (TG) and glucose levels were measured and pathological changes of aorta intima and liver were analyzed. RESULTS: A significant elevated TC, TG and glucose levels in plasma with progress of time in young treble gene mutant mice were observed, which were higher than that in ApoE-/-/LDLR-/- and Leprdb/db mutants. At time of only 2 weeks after fed with high fat/cholesterol diet, TC and TG levels reached (106.75±3.40) mmol/L, (9.12±1.35) mmol/L, respectively in treble gene mutant mice, 4.33- and 2.36-fold higher than those in treble genes mutants fed with normal chow diet. The levels were continuously increased until final experimental point. Intima of the aorta appeared with various injuries such as edema, desquamation of the endothelial cells, foam cell formation, rupture of IEL in local regions of root and arch areas of aorta at 2 weeks after fed with high fat/cholesterol diet. Microscopic pathological complex of significant local intima incrassation and fatty change of the liver were observed in the mutants that fed with high fat/cholesterol diet for 8 weeks. Injuries of aorta were severe than normal dietetic control group. CONCLUSION: High fat/cholesterol diet as a key dietary factor is significant aggravated lipid metabolism abnormity, promotes early damage of aorta and process of atherogenesis in the treble genes mutants.     

Role of type II innate lymphoid cells in browning of white adipose tissue

Type II innate lymphoid cells (ILC2s) are widely distributed in the blood, intestines, trachea, lung, spleen, liver, animal fat and skin, and involved in the innate immune responses. ILC2s have attracted much attention for its important roles in the conversion of white adipose to beige adipose. Studies have shown that ILC2s are essential for the proliferation and differentiation of adipocyte precursor cells, and they also play a vital role in anti-parasitic infection and allergic inflammation. This review discusses the discovery, differentiation, development, distribution and function of ILC2s, and their relationships with the browning of white adipose tissue for providing valuable references on understanding the pathogenesis, prevention and treatment of obesity and fat metabolism disorders.     

CYP450 epoxygenase/EET pathway attenuates adipose inflammation of obese mice through HIF-1α

AIM To investigate the effects of cytochrome P450 （CYP450） epoxygenase/epoxyeicosatrienoic acid （EET） pathway on insulin resistance in obese mice， and to explore the possible mechanisms. METHODS High-fat diet-induced obesity model was established in C57BL/6Cnc mice， and the obese mice were randomly divided into 3 groups， including obesity group （treated with saline； n=10）， EET group （treated with 11，12-EET； n=10） and EET inhibitor 14，15-epoxyeicosa-5（Z）-enoic acid （EEZE） group （n=10）. Normal C57BL/6Cnc mice （n=10） treated with saline served as control. Protein expression of CYP2J2 （one of CYP450 epoxygenases） and hypoxia-inducible factor-1α （HIF-1α） was measured by Western blot. Vessel-like structure was detected by immunofluorescence staining. The serum levels of insulin， tumor necrosis factor-α （TNF-α）， interleukin （IL）-1β， IL-6 and monocyte chemoattractant protein-1 （MCP-1） were measured by ELISA. RESULTS In obese mice， homeostasis model assessment of insulin resistance （HOMA-IR） values were increased， the protein level of CYP2J2 was reduced， and the protein level of HIF-1α was increased in adipose tissues as compared with the controls （P<0.05）. The serum levels of MCP-1， IL-1β， IL-6 and TNF-α were also significantly increased in obese mice （P<0.05）. After treatment with 11， 12-EET， the HOMA-IR values were decreased compared with vehicle-treated obese mice， HIF-1α expression levels were decreased in the adipose tissue， and the serum levels of MCP-1， IL-1β， IL-6 and TNF-α were reduced （P<0.05）. Immunohistochemical results of adipose tissue from vehicle-treated obese mice showed a marked decrease in vessel-like structures （CD31-positive） compared with normal control mice （P<0.05）. EET treatment significantly increased the newly formed vessel-like structures in the visceral adipose tissues of obese mice as compared with vehicle-treated obese mice （P<0.05）. CONCLUSION High-fat diet-induced obesity and insulin resistance are closely related to the CYP450 pathway. Exogenous EETs effectively decrease obesity-induced insulin resistance possibly through pro-angiogenesis and attenuation of hypoxia and inflammation.     

Effects of Astragalus injection combined with puerarin injection on expression of BMP-7 and TGF-β1 in type 2 diabetic KKAy mouse kidney

AIM: To observe the effects of Astragalus injection combined with puerarin injection on the expression of transforming growth factor beta 1 (TGF-β₁) and bone morphogenetic protein 7 (BMP-7) in the kidney of type 2 diabetic KKA^y mouse. METHODS: The male KKA^y mice of 14 weeks old were randomly divided into model group and Astragalus injection combined with puerarin injection treatment (Astragalus+puerarin) group. The age-matched male C57BL/6J mice were selected as normal group. The general conditions and body weight of the mice were observed. Blood glucose (BG), triglyceride (TG), cholesterol (TC) and serum creatinine (SCr) were examined at the 20th, 24th and 28th week. The protein expression of renal TGF-β₁ was determined by immunohistochemical method. The mRNA expression of BMP-7 and TGF-β₁ was detected by RT-PCR. RESULTS: Compared with normal group, the body weight, BG, TG, TC and SCr increased significantly in model group. TGF-β₁ expression at protein and mRNA levels was increased, while mRNA expression of BMP-7 was decreased in KKA^y mice. Compared with model group, the body weight, BG, TG, TC and SCr reduced in Astragalus+puerarin group. The mRNA expression of BMP-7 in the renal tissues was higher, and TGF-β₁ expression at mRNA and protein levels was significantly lower in Astragalus+puerarin group than those in model group. CONCLUSION: Astragalus injection combined with puerarin injection has renal protective effects on type 2 diabetic KKA^y mice. The mechanism may be related to restoring BMP-7 expression and reducing the overexpression of TGF-β₁ in renal tissues.     

Liraglutide ameliorates liver injury of type 2 diabetic mice via micro-RNA-33-AMPK pathway

AIM: To observe the effects of liraglutide on the level of microRNA-33 (miR-33) and the expression of AMP-activated protein kinase (AMPK) and apoptosis-related proteins in mice with type 2 diabetes mellitus (T2DM), and to explore its possible mechanism. METHODS: High-fat diet and intraperitoneal injection of streptozocin were used to establish the type 2 diabetic model in C57BL/6 mice. The mice were randomly divided into 4 groups (n=15):in control group, the normal mice were subcutaneously injected with equivalent volume of saline; in model group, the T2DM mice were subcutaneously injected with equivalent volume of saline; in low-and high-dose liraglutide treatment groups, the T2DM mice were subcutaneously injected with 100 and 200 μg·kg^-1·d^-1, respectively. After 4 weeks of administration, the levels of FBG, TG, TC, HDL-C, LDL-C, ALT and AST were determined. HE staining was used to observe the pathological changes of the liver tissues. The protein level of cleaved caspase-3 in the liver tissue was detected by the technique of immunofluorescence. The protein levels of p-AMPK/AMPK and apoptosis-related proteins were detected by Western blot. The expression of miR-33 in the liver tissues was detected by real-time PCR. RESULTS: Compared with model group, the contents of FBG, TG, TC, LDL-C, ALT and AST were decreased significantly, while the content of HDL-C was increased significantly in low-dose liraglutide group and high-dose liraglutide group (P<0.05). The protein levels of phosphorylated AMPK and Bcl-2 were up-regulated significantly, and the expression of cleaved caspase-3 was down-regulated significantly (P<0.05). The level of miR-33 was decreased significantly (P<0.01). CONCLUSION: Liraglutide alleviates liver injury in type 2 diabetic mice, and the mechanism may be associated with reducing the level of miR-33 and increasing the phosphorylation of AMPK in the liver tissues, thereby inhibiting hepatocyte apoptosis.